Table 4.

Time to start treatment and treatment adherence to clinical practice guidelines by country.

Time to start treatment and treatment adherence to clinical practice guidelines
Country	Indicator 2. Time to start RT or surgery		Indicator 3. Time in starting adjuvant therapy		Indicator 4% of patients with L disease stage treated with surgery or RT			Indicator 5% of patients with A disease stage treated with multi therapy
	N treated with surgery or RT	% starting surgery or RT <1 month from diagnosis	N with adjuvant therapy	% starting adjuvant therapy <8 weeks from the surgery	N with L disease	% treated with surgery alone or RT alone	M%	N with A disease	% treated with multi therapy	M%
Ireland	1,055	41	202	33	332	72	8	640	43	5
Italy	595	61	94	52	327	75	13	380	19	15
Netherlands	4,741	39	900	79	2,792	79	10	3,005	21	22
Slovenia	198	41	69	57	119	72	3	90	44	3

Indicator 2: Number (N) of head and neck cancer patients treated with surgery or radiotherapy (RT), percentage (%) of patients treated with surgery or RT starting surgery or RT <1 month from diagnosis. Indicator 3: Number (N) of head and neck cancer patients treated with adjuvant therapy^* percentage (%) of head and neck patients starting adjuvant therapy <8 weeks from the surgery. Indicator 4: Number (N) of head and neck cancer patients with localized disease (L), percentage (%) of head and neck cancer patients with localized (L) disease treated with surgery alone or RT alone and percentage (%) of missing (M) information for this indicator. Indicator 5: Number (N) of head and neck cancer patients with advanced disease (A), percentage (%) of head and neck cancer patients with advanced (A) disease treated with multi therapy^** and percentage (%) of missing (M) information for this indicator. ^*Adjuvant therapy: post-operative radiotherapy or post-operative concomitant chemo-radiotherapy. ^**Multi therapy: surgery plus post-operative radiotherapy or post-operative chemo-radiotherapy or concomitant chemo-radiotherapy alone.